Studies have reported that SEPT9 promotes breast cancer EMT through activation of the FAK/Src signaling pathway by negatively regulating the ARHGAP4 protein in the Rho-GAP family [23]. This evidence concerns the gene ARHGAP4 and breast carcinoma.